Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors

被引：21
|
作者：
Abdellatif, Khaled R. A. [1 ,2 ]
Abdelgawad, Mohamed A. [1 ,3 ]
Labib, Madlen B. [1 ]
Zidan, Taha H.
机构：
[1] Beni Suef Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Bani Suwayf 62514, Egypt
[2] Ibn Sina Natl Coll Med Studies, Dept Pharmaceut Sci, Jeddah, Saudi Arabia
[3] Aljouf Univ, Coll Pharm, Dept Pharmaceut Chem, Sakaka, Aljouf, Saudi Arabia
来源：
ARCHIV DER PHARMAZIE | 2017年 / 350卷 / 08期
关键词：
Anti-inflammatory; Imidazoline; Pyrazole; Selective COX-2 inhibitor; DONOR ESTER PRODRUGS; ANTIINFLAMMATORY EVALUATION; CYCLOOXYGENASE INHIBITION; DESIGN;
D O I：
10.1002/ardp.201600386
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
New series of diarylpyrazoles 8a-f and triarylimidazoline-5-ones 11a-g were synthesized and evaluated for their in vitro cyclooxygenase-1 (COX-1) and COX-2 inhibitory activity and in vivo anti-inflammatory activity. The synthesized compounds showed good selectivity for COX-2; compounds 8a, 8d, 8f, 11a, and 11c exhibited the highest COX-2 selectivity indexes (SI=4.77-5.43) compared to the reference drug celecoxib (SI=7.8). All compounds showed good in vivo anti-inflammatory activity, especially compounds 8a, 8f, 11c, and 11d, which also showed some similarities to the time interval pattern of celecoxib at all different time intervals (1, 3, and 6h).
引用
收藏
页数：10
相关论文
共 50 条
  • [21] Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation
    Ghoneim, Mohammed M.
    Abdelgawad, Mohamed A.
    Elkanzi, Nadia A. A.
    Bakr, Rania B.
    MOLECULAR DIVERSITY, 2025, 29 (02) : 1789 - 1820
  • [22] Selective COX-2 inhibitors. Part 1: Synthesis and biological evaluation of phenylazobenzenesulfonamides
    Tsai, Wei-Jern
    Shiao, Young-Ji
    Lin, Shwu-Jiuan
    Chiou, Wen-Fei
    Lin, Lie-Chwen
    Yang, Tsang-Hsiung
    Teng, Che-Ming
    Wu, Tain-Shung
    Yang, Li-Ming
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4440 - 4443
  • [23] Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2/5-LOX inhibitors
    Shaaban, Mohamed A.
    Kamal, Aliaa M.
    Faggal, Samar, I
    Farag, Nahla A.
    Aborehab, Nora M.
    Elsahar, Ayman E.
    Mohamed, Khaled O.
    ARCHIV DER PHARMAZIE, 2020, 353 (11)
  • [24] Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition
    Ren, Shen-Zhen
    Wang, Zhong-Chang
    Zhu, Xiao-Hua
    Zhu, Dan
    Li, Zhang
    Shen, Fa-Qian
    Duan, Yong-Tao
    Cao, Han
    Zhao, Jing
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (14) : 4264 - 4275
  • [25] Synthesis, Biological Activity, and Molecular Modeling Studies of Pyrazole and Triazole Derivatives as Selective COX-2 Inhibitors
    Assali, Mohyeddin
    Abualhasan, Murad
    Sawaftah, Hadeel
    Hawash, Mohammed
    Mousa, Ahmed
    JOURNAL OF CHEMISTRY, 2020, 2020
  • [26] Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors
    Murahari, Manikanta
    Mahajan, Vivek
    Neeladri, Sreenivasulu
    Kumar, Maushmi S.
    Mayur, Y. C.
    BIOORGANIC CHEMISTRY, 2019, 86 : 583 - 597
  • [27] Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors
    Gedawy, Ehab M.
    Kassab, Asmaa E.
    El Kerdawy, Ahmed M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 189
  • [28] Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors
    Eren, Goekcen
    Unlu, Serdar
    Nunez, Maria-Teresa
    Labeaga, Luis
    Ledo, Francisco
    Entrena, Antonio
    Banoglu, Erden
    Costantino, Gabriele
    Sahin, M. Fethi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) : 6367 - 6376
  • [29] Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
    Hassanein, Hassanein H.
    Georgey, Hanan H.
    Fouad, Marwa A.
    El Kerdawy, Ahmed M.
    Said, Mona F.
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (06) : 553 - 578
  • [30] New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation
    Bokhtia, Riham M.
    Panda, Siva S.
    Girgis, Adel S.
    Samir, Nermin
    Said, Mona F.
    Abdelnaser, Anwar
    Nasr, Soad
    Bekheit, Mohamed S.
    Dawood, Abdelhameed S.
    Sharma, Horrick
    Wade, Margaret
    Sharma, Swapnil K.
    Ghanim, Amany M.
    MOLECULES, 2023, 28 (04):
12345